Clinical trialNCT06234488Active, not recruitingObservational

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

SponsorMedical College of WisconsinEnrollment125Breast AdenocarcinomaBreast CancerBreast Cancer InvasiveBreast Cancer StageBreast Cancer Stage IVBreast Cancer in Situ+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Chandler S Cortina
The Medical College of Wisconsin
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Southern California/los Angeles (usc/la County)
Los Angeles, California, United States
University of California San Francisco (ucsf)
San Francisco, California, United States
University of Colorado Anschutz Medical Campus (cu Anschutz)
Aurora, Colorado, United States
Medstar Georgetown University Hospital (mguh)
Washington D.C., District of Columbia, United States
Mayo Clinic
Jacksonville, Florida, United States
Moffitt Cancer Center (mcc)
Tampa, Florida, United States
Northwestern Medicine
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Northshore University Health System
Evanston, Illinois, United States
Birgham and Women'S Hospital
Boston, Massachusetts, United States
Boston University (boston U)
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
New York University (nyu)
New York, New York, United States
University of Rochester
Rochester, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Cleveland Clinic Foundation (ccf)
Cleveland, Ohio, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Vanderbilt University Medical Center (vumc)
Nashville, Tennessee, United States
University of Washington (uw)
Seattle, Washington, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Dec 2023
Primary completion: 1 Nov 2024
Completion: 30 Aug 2026
Last update posted: 12 Jan 2026
Registered enrollment: 125
Registry id: NCT06234488

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.